Thermo Fisher Scientific, Inc. (TMO)
609.82
+6.64
(+1.10%)
USD |
NYSE |
Sep 11, 16:00
614.08
+4.26
(+0.70%)
Pre-Market: 06:38
Thermo Fisher Scientific Enterprise Value : 264.08B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 264.08B |
| September 10, 2026 | 261.63B |
| September 09, 2026 | 262.55B |
| September 08, 2026 | 261.57B |
| September 04, 2026 | 265.55B |
| September 03, 2026 | 267.26B |
| September 02, 2026 | 263.61B |
| September 01, 2026 | 260.64B |
| August 31, 2026 | 266.77B |
| August 28, 2026 | 268.65B |
| August 27, 2026 | 271.80B |
| August 26, 2026 | 272.91B |
| August 25, 2026 | 270.86B |
| August 24, 2026 | 271.08B |
| August 21, 2026 | 271.27B |
| August 20, 2026 | 270.64B |
| August 19, 2026 | 265.46B |
| August 18, 2026 | 256.40B |
| August 17, 2026 | 255.09B |
| August 14, 2026 | 256.12B |
| August 13, 2026 | 258.93B |
| August 12, 2026 | 261.56B |
| August 11, 2026 | 262.30B |
| August 10, 2026 | 260.34B |
| August 07, 2026 | 258.23B |
| Date | Value |
|---|---|
| August 06, 2026 | 253.06B |
| August 05, 2026 | 252.25B |
| August 04, 2026 | 247.42B |
| August 03, 2026 | 250.85B |
| July 31, 2026 | 250.95B |
| July 30, 2026 | 251.86B |
| July 29, 2026 | 251.75B |
| July 28, 2026 | 251.73B |
| July 27, 2026 | 245.49B |
| July 24, 2026 | 248.71B |
| July 23, 2026 | 250.22B |
| July 22, 2026 | 233.26B |
| July 21, 2026 | 232.15B |
| July 20, 2026 | 233.17B |
| July 17, 2026 | 235.49B |
| July 16, 2026 | 239.45B |
| July 15, 2026 | 236.52B |
| July 14, 2026 | 236.07B |
| July 13, 2026 | 234.02B |
| July 10, 2026 | 233.48B |
| July 09, 2026 | 232.61B |
| July 08, 2026 | 227.22B |
| July 07, 2026 | 229.62B |
| July 06, 2026 | 229.98B |
| July 02, 2026 | 232.14B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 43.62B |
| Danaher Corp. | 164.20B |
| Illumina, Inc. | 32.53B |
| Bio-Rad Laboratories, Inc. | 9.625B |
| Revvity, Inc. | 16.19B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.742B |
| Revenue (Quarterly) | 11.99B |
| Total Expenses (Quarterly) | 10.26B |
| EPS Diluted (Quarterly) | 4.679 |
| Gross Profit Margin (Quarterly) | 40.94% |
| Profit Margin (Quarterly) | 14.52% |
| Earnings Yield | 3.05% |
| Operating Earnings Yield | 3.87% |
| Normalized Earnings Yield | 3.139 |